Meet BrosMed at SBHCI Congress 2022
Release time:
2022-06-22
BrosMed Medical will participate in the upcoming SBHCI Congress 2022 from 29 June to 01 July at the Expominas Exhibition Pavilion in Belo Horizonte, Brazil.
BrosMed Medical will participate in the upcoming SBHCI Congress 2022 from 29 June to 01 July at the Expominas Exhibition Pavilion in Belo Horizonte, Brazil.
Be sure to come and visit us at booth 34 and get to know our products of cardiovascular intervention and interventional accessories:
Alveo™ HP CTO Balloon Dilatation Catheter
Pronavi™ Microcatheter
POT™ PTCA NC Balloon Dilatation Catheter
Interventional Accessories
Please contact us via Email: sales@brosmed.com if you are interested in participating in the largest congress of interventional cardiology in Brazil. We are delighted to meet you there and get inspiration from each other!
Let’s share experiences with each other from various parts of the world and meet unprecedented technologies designed to promote improvements in health and preservation of life.
About BrosMed Medical
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), three manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 40 product series and 150+ products registration certificates in worldwide.
About SBHCI Congress
The Brazilian Society of Interventional Cardiology (SBHCI) is a non-profit organization since 1975 with approximately 1,000 members from all over Brazil. SBHCI goals are to develop interventional cardiology in Brazil, certify professional performance and represent associates with quality, efficiency and high added value for the benefit of the community.
The Brazilian Congress of Interventional Cardiology is promoted by the society, and occurs yearly in different cities of Brazil, with the participation of more than 1000 delegates from Brazil, Latin America, USA and Europe.
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
